Mirum Pharmaceuticals, Inc. MIRM Total debt

Total debt at other companies

Gilead SciencesGILD

$26.25B+5.2%

Rhythm Pharmaceuticals, Inc.RYTM

$112.31M-1.1%

LQD

Liquidia CorporationLQDA

$6.96M+1.5%

ALN

Alnylam PharmaceuticalsALNY

$256.43M-5.2%

BridgeBio PharmaBBIO

$3.26B+32,101%

Arrowhead ResearchARWR

$107.88M-5.6%

FAQ

What is Mirum Pharmaceuticals, Inc.'s total debt?

Mirum Pharmaceuticals, Inc. (MIRM) reported total debt of $12.87M in Q2 2026.

How has Mirum Pharmaceuticals, Inc.'s total debt changed year-over-year?

Mirum Pharmaceuticals, Inc.'s total debt increased by 29.2% year-over-year, from $9.97M to $12.87M.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s total debt?

Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s total debt has grown at a 24.2% compound annual growth rate (CAGR), from $3.26M to $9.66M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.